ATLANTA-- Immune memory after smallpox vaccination persists for at least 50 years in immunized individuals, according to research conducted by scientists at the Emory Vaccine Center and Emory University School of Medicine. This is good news, since the findings, published in the Nov. 15 issue of the Journal of Immunology, suggest that individuals vaccinated against smallpox prior to the end of the smallpox vaccination program in 1972 may still retain at least some protection against smallpox.
Rafi Ahmed, PhD, Georgia Research Alliance Eminent Scholar and director of the Emory Vaccine Center, was principal investigator of the research study, and Shane Crotty, PhD, formerly at Emory University School of Medicine and currently a faculty member at The La Jolla Institute for Allergy and Immunology, was first author. Other members of the research team included Emory microbiologist John Glidewell, Phil Felgner, and Luis Villarreal of the University of California, Irvine, and Huw Davies of King's College London.
Although scientists have known that acute viral infections and vaccines produce two types of long-term immune memory that provide protection against disease, they are still learning the details of these immune mechanisms.
Using a new blood test they developed to assess human antigen-specific immunity, the Emory scientists measured memory B cell responses in individuals recently vaccinated with smallpox vaccine (DryVax), in unvaccinated individuals, and in individuals vaccinated between three months and 60 years earlier. The recently vaccinated group showed a significant virus-specific memory B cell response to vaccinia, while the unvaccinated individuals were negative for vaccinia virus-specific memory B cells. Vaccinia virus-specific B cells were detected in most of the previously vaccinated individuals in the study, including those vaccinated up to 60 years after vaccination.
The scientists found that virus-specific memory B cells initiaPage: 1 2 3 Related medicine news :1
Contact: Holly Korschun
Emory University Health Sciences Center
. Immune therapy appears to reduce risk of second attack of multiple sclerosis symptoms2
. Immune cells may play important role in progression of type 1 diabetes, Joslin researchers find3
. Immune alarm system can both amplify and silence alerts, scientists find4
. Immune response to Alzheimer diseaserelated protein changes as we age5
. Immune system supressor drug found effective in treating precancerous blood disorder6
. Immune system in hamsters bolstered during winter, especially in times of stress, study finds7
. Immune system protein may be critical in kidney disorders and other diseases8
. Immune system cells surprisingly high in HIV-infected adolescents, says researcher at the Childrens Hospital of Philadelphia9
. Immune system responds greater to uncontrollable stresses10
. Immune system rebounds for some children with AIDS, finds UF study11
. Immunex Files Supplemental NDA for NOVANTRONE